1274944

Astellas Pharma Inc. — FEI 3002807001

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Takaoka (Japan)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
145221 CFR 211.113(b)Validation lacking for sterile drug products